CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition

Cancer Letters

Volumn 348, Issue 1-2, 2014, Pages 77-87

  Cheng, Xian Shuo ^a,b   Li, Yun Feng ^b   Tan, Jing ^b   Sun, Bin ^a   Xiao, You Chuan ^b   Fang, Xing Bao ^b   Zhang, Xiao Feng ^a   Li, Qiang ^b   Dong, Jian Hua ^b   Li, Ming ^b   Qian, Hai hua ^a   Yin, Zheng Feng ^a   Yang, Zhi Bin ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

CCL20; Colorectal cancer; CXCL8 interleukin 8; Epithelial mesenchymal transition; Prognosis

Indexed keywords

INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CANCER; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CCL20; COLORECTAL CANCER; CXCL8/INTERLEUKIN-8; EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; CACO-2 CELLS; CADHERINS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL20; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; INTERLEUKIN-8; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; YOUNG ADULT;

EID: 84900500082     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.03.008     Document Type: Article

References (58)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90. PubMed: 21296855.
2. Holzel D., Eckel R., Engel J. Colorectal cancer metastasis. Frequency, prognosis, and consequences. Chirurg 2009, 80:331-340. PubMed: 18820881.
3. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127. PubMed: 10714678.
4. Hieshima K., Imai T., Opdenakker G., Van Damme J., Kusuda J., Tei H., Sakaki Y., Takatsuki K., Miura R., Yoshie O., Nomiyama H. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J. Biol. Chem. 1997, 272:5846-5853. PubMed: 9038201.
5. Schutyser E., Struyf S., Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytok. Growth Fact. Rev. 2003, 14:409-426. PubMed: 12948524.
6. Ghadjar P., Coupland S.E., Na I.K., Noutsias M., Letsch A., Stroux A., Bauer S., Buhr H.J., Thiel E., Scheibenbogen C., Keilholz U. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J. Clin. Oncol. 2006, 24:1910-1916. PubMed: 16622267.
7. Rubie C., Oliveira V., Kempf K., Wagner M., Tilton B., Rau B., Kruse B., Konig J., Schilling M. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol. 2006, 27:166-174. PubMed: 17075975.
8. Frick V.O., Rubie C., Kolsch K., Wagner M., Ghadjar P., Graeber S., Glanemann M. CCR6/CCL20chemokine expression profile in distinct colorectal malignancies. Scand. J. Immunol. 2013, 78:298-305. PubMed: 23790181.
9. Rubie C., Frick V.O., Ghadjar P., Wagner M., Justinger C., Graeber S., Sperling J., Kollmar O., Schilling M.K. Effect of preoperative FOLFOX chemotherapy onCCL20/CCR6 expression in colorectal liver metastases. World J. Gastroenterol. 2011, 17:3109-3116. PubMed: 21912453.
10. Vicinus B., Rubie C., Stegmaier N., Frick V.O., Kolsch K., Kauffels A., Ghadjar P., Wagner M., Glanemann M. MiR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation. Oncol. Rep. 2013, 30:1285-1292. PubMed: 23817679.
11. Yang C.C., Ogawa H., Dwinell M.B., McCole D.F., Eckmann L., Kagnoff M.F. Chemokine receptor CCR6 transduces signals that activate p130Cas and alter cAMP-stimulated ion transport in human intestinal epithelial cells. Am. J. Physiol. Cell Physio. 2004, 288:C321-C328. PubMed: 15483227.
12. Dellacasagrande J., Schreurs O.J., Hofgaard P.O., Omholt H., Steinsvoll S., Schenck K., Bogen B., Dembic Z. Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand. J. Immunol. 2003, 57:534-544. PubMed: 12791091.
13. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008, 14:6735-6741. PubMed: 18980965.
14. Baier P.K., Eggstein S., Wolff-Vorbeck G., Baumgartner U., Hopt U.T. Chemokines in human colorectal carcinoma. Anticancer Res. 2005, 25:3581-3584. PubMed: 16101183.
15. Doll D., Keller L., Maak M., Boulesteix A.L., Siewert J.R., Holzmann B., Janssen K.P. Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Int. J. Colorectal. Dis. 2010, 25:573-581. PubMed: 20162422.
16. Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurje G., Winder T., Yang D., LaBonte M.J., Wilson P.M., Ladner R.D., Lenz H.J. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 2011, 128:2038-2049. PubMed: 20648559.
17. Rubie C., Frick V.O., Pfeil S., Wagner M., Kollmar O., Kopp B., Graber S., Rau B.M., Schilling M.K. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J. Gastroenterol. 2007, 13:4996-5002. PubMed: 17854143.
18. Li A., Varney M.L., Singh R.K. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin. Cancer Res. 2001, 7:3298-3304. PubMed: 11595728.
19. Lee Y.S., Choi I., Ning Y., Kim N.Y., Khatchadourian V., Yang D., Chung H.K., Choi D., LaBonte M.J., Ladner R.D., Nagulapalli Venkata K.C., Rosenberg D.O., Petasis N.A., Lenz H.J., Hong Y.K. Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br. J. Cancer 2012, 106:1833-1841. PubMed: 22617157.
20. Dimberg J., Strom K., Lofgren S., Zar N., Lindh M., Matussek A. DNA promoter methylation status and protein expression ofinterleukin-8in human colorectal adenocarcinomas. Int. J. Colorectal. Dis. 2012, 27:709-714. PubMed: 22108905.
21. Kantola T., Klintrup K., Väyrynen J.P., Vornanen J., Bloigu R., Karhu T., Herzig K.H., Näpänkangas J., Mäkelä J., Karttunen T.J., Tuomisto A., Mäkinen M.J. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br. J. Cancer 2012, 107:1729-1736. PubMed: 23059742.
22. Choi J.W., Liu H., Shin D.H., Yu G.I., Hwang J.S., Kim E.S., Yun J.W. Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients. Proteomics 2013, 13:2361-2374. PubMed: 23606366.
23. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890. PubMed: 19945376.
24. Onoue T., Uchida D., Begum N.M., Tomizuka Y., Yoshida H., Sato M. Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int. J. Oncol. 2006, 29:1133-1138. PubMed: 17016644.
25. Matsushita K., Toiyama Y., Tanaka K., Saigusa S., Hiro J., Uchida K., Inoue Y., Kusunoki M. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients. Ann. Surg. Oncol. Suppl. 2011, S518-S527. PubMed: 21845497.
26. Chen J., Yao Y., Gong C., Yu F., Su S., Chen J., Liu B., Deng H., Wang F., Lin L., Yao H., Su F., Anderson K.S., Liu Q., Ewen M.E., Yao X., Song E. CCL18 from tumor associated macrophages promotes breast cancer cells via PITPNM3. Cancer Cell 2011, 19:541-555. PubMed: 21481794.
27. Fernando R.I., Castillo M.D., Litzinger M., Hamilton D.H., Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 2011, 71:5296-5306. PubMed: 21653678.
28. Li X.J., Peng L.X., Shao J.Y., Lu W.H., Zhang J.X., Chen S., Chen Z.Y., Xiang Y.Q., Bao Y.N., Zheng F.J., Zeng M.S., Kang T.B., Zeng Y.X., Teh B.T., Qian C.N. As an independent unfavorable prognostic factor,IL-8promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling. Carcinogenesis 2012, 33:1302-1309. PubMed: 22610073.
29. Remmele W., Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987, 8:138-140. PubMed: 3303008.
30. Wen W., Ding J., Sun W., Fu J., Chen Y., Wu K., Ning B., Han T., Huang L., Chen C., Xie D., Li Z., Feng G., Wu M., Xie W., Wang H. Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression. Hepatology 2012, 55:1787-1798. PubMed: 22271581.
31. Lo H.W., Hsu S.C., Xia W., Cao X., Shih J.Y., Wei Y., Abbruzzese J.L., Hortobagyi G.N., Hung M.C. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 2007, 67:9066-9076. PubMed: 17909010.
32. Chen X.F., Zhang H.J., Wang H.B., Zhu J., Zhou W.Y., Zhang H., Zhao M.C., Su J.M., Gao W., Zhang L., Fei K., Zhang H.T., Wang H.Y. Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/ERK1/2 signaling pathways. Mol. Biol. Rep. 2012, 39:3549-3556. PubMed: 21713404.
33. Larue L., Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005, 24:7443-7454. PubMed: 16288291.
34. Tan S., Ng Y., James D.E. Next-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes. Biochem. J. 2011, 435:539-544. PubMed: 21348862.
35. Wilhelm S.M., Carter C., Tang L., Wilkie D., McNabola A., Rong H., Chen C., Zhang X., Vincent P., McHugh M., Cao Y., Shujath J., Gawlak S., Eveleigh D., Rowley B., Liu L., Adnane L., Lynch M., Auclair D., Taylor I., Gedrich R., Voznesensky A., Riedl B., Post L.E., Bollag G., Trail P.A. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 2004, 64:7099-7109. PubMed: 15466206.
36. Kakinuma T., Hwang S.T. Chemokines, chemokine receptors, and cancer metastasis. J. Leukoc. Biol. 2006, 79:639-651. PubMed: 16478915.
37. Ghadjar P., Rubie C., Aebersold D.M., Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int. J. Cancer 2009, 125:741-745. PubMed: 19480006.
38. Brew R., Erikson J.S., West D.C., Kinsella A.R., Slavin J., Christmas S.E. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000, 12:78-85. PubMed: 10623446.
39. Bailey C., Negus R., Morris A., Ziprin P., Goldin R., Allavena P., Peck D., Darzi A. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin. Exp. Metastasis 2007, 24:121-130. PubMed: 17390111.
40. Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol. 2009, 174:1588-1593. PubMed: 19342369.
41. Leroy P., Mostov K.E. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol. Biol. Cell. 2007, 18:1943-1952. PubMed: 17344479.
42. Arnoux V., Nassour M., L'Helgoualc'h A., Hipskind R.A., Savagner P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol. Biol. Cell 2008, 19:4738-4749. PubMed: 18716062.
43. Revenu C., Gilmour D. EMT 2.0: shaping epithelia through collective migration. Curr. Opin. Genet. Dev. 2009, 19:338-342. PubMed: 19464162.
44. Choi S.S., Diehl A.M. Epithelial-to-mesenchymal transitions in the liver. Hepatology 2009, 50:2007-2013. PubMed: 19824076.
45. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454. PubMed: 12189386.
46. Wang H., Zhang G., Zhang H., Zhang F., Zhou B., Ning F., Wang H.S., Cai S.H., Du J. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway. Eur. J. Pharmacol. 2013, 723:156-166. PubMed: 24333218.
47. V. Gnemmi, A. Bouillez, K. Gaudelot, B. Hémon, B. Ringot, N. Pottier, F. Glowacki, A. Villers, D. Vindrieux, C. Cauffiez, I.V. Seuningen, D. Bernard, X. Leroy, S. Aubert, M. Perrais, MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter. Cancer Lett. doi:10.1016/j.canlet.2013.12.029 (Epub ahead of print) (PubMed: 24384091).
48. Grille S.J., Bellacosa A., Upson J., Klein-Szanto A.J., van Roy F., Lee-Kwon W., Donowitz M., Tsichlis P.N., Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 2003, 63:2172-2178. PubMed: 12727836.
49. Chen G., Chen S.M., Wang X., Ding X.F., Ding J., Meng L.H. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. J. Biol. Chem. 2012, 287:12132-12141. PubMed: 22337890.
50. Wang L., Li C.L., Wang L., Yu W.B., Yin H.P., Zhang G.Y., Zhang L.F., Li S., Hu S.Y. Influence of CXCR4/SDF-1 axis on E-cadherin/beta-catenin complex expression in HT29 colon cancer cells. World J. Gastroenterol. 2011, 17:625-632. PubMed: 21350711.
51. Huang C.Y., Fong Y.C., Lee C.Y., Chen M.Y., Tsai H.C., Hsu H.C., Tang C.H. CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. Biochem. Pharmacol. 2009, 77:794-803. PubMed: 19073147.
52. Brand S., Olszak T., Beigel F., Diebold J., Otte J.M., Eichhorst S.T., Göke B., Dambacher J. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J. Cell Biochem. 2006, 97:709-723. PubMed: 16215992.
53. Ju D., Sun D., Xiu L., Meng X., Zhang C., Wei P. Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells. Med. Oncol. 2012, 29:91-99. PubMed: 21191670.
54. Wehler T.C., Hamdi S., Maderer A., Graf C., Gockel I., Schmidtmann I., Hainz M., Berger M.R., Theobald M., Galle P.R., Moehler M., Schimanski C.C. Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft-no benefit of combination therapy. Int. J. Colorectal. Dis. 2013, 28:385-398. PubMed: 22983756.
55. Hwang W.L., Yang M.H., Tsai M.L., Lan H.Y., Su S.H., Chang S.C., Teng H.W., Yang S.H., Lan Y.T., Chiou S.H., Wang H.W. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011, 141(279-291):e1-e5. PubMed: 21640118.
56. Rial N.S., Lazennec G., Prasad A.R., Krouse R.S., Lance P., Gerner E.W. Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer. Int. J. Cancer 2009, 124:2270-2280. PubMed: 19173296.
57. Oladipo O., Conlon S., O'Grady A., Purcell C., Wilson C., Maxwell P.J., Johnston P.G., Stevenson M., Kay E.W., Wilson R.H., Waugh D.J. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. Br. J. Cancer 2011, 104:480-487. PubMed: 21285972.
58. Terada H., Urano T., Konno H. Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer. Eur. Surg. Res. 2005, 37:166-172. PubMed: 16088182.